Silodosin

URYDOS-8 contains Silodosin 8 mg, a selective alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck, improving urine flow and relieving obstruction.

It is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH), helping reduce urinary frequency, urgency, weak stream, and incomplete bladder emptying. The 8 mg dosage is commonly used for patients requiring higher symptom control, while maintaining a favorable safety profile with minimal blood pressure effects due to its high alpha-1A selectivity.